These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19426821)

  • 21. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
    Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus.
    Roesler R; Valvassori SS; Castro AA; Luft T; Schwartsmann G; Quevedo J
    Peptides; 2009 Jun; 30(6):1192-6. PubMed ID: 19463755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis.
    Oliveira PG; Grespan R; Pinto LG; Meurer L; Brenol JC; Roesler R; Schwartsmann G; Cunha FQ; Xavier RM
    Arthritis Rheum; 2011 Oct; 63(10):2956-65. PubMed ID: 21953084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice.
    Matsumoto Y; Yokoi H; Kimura T; Matsumoto Y; Kawada M; Arae K; Nakae S; Ikeda T; Matsumoto K; Sakurai H; Saito K
    Laryngoscope; 2018 Nov; 128(11):E377-E384. PubMed ID: 30151920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consequence of gastrin-releasing peptide receptor activation in a human colon cancer cell line: a proteomic approach.
    Ruginis T; Taglia L; Matusiak D; Lee BS; Benya RV
    J Proteome Res; 2006 Jun; 5(6):1460-8. PubMed ID: 16739997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of gastrin releasing Peptide receptor in renal cell carcinomas: a potential function for the regulation of neoangiogenesis and microvascular perfusion.
    Heuser M; Schlott T; Schally AV; Kahler E; Schliephake R; Laabs SO; Hemmerlein B
    J Urol; 2005 Jun; 173(6):2154-9. PubMed ID: 15879878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase 8 in neuroblastoma tumorigenesis.
    Oehme I; Deubzer HE; Wegener D; Pickert D; Linke JP; Hero B; Kopp-Schneider A; Westermann F; Ulrich SM; von Deimling A; Fischer M; Witt O
    Clin Cancer Res; 2009 Jan; 15(1):91-9. PubMed ID: 19118036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095.
    Martins MR; Reinke A; Valvassori SS; Machado RA; Quevedo J; Schwartsmann G; Roesler R
    Peptides; 2005 Dec; 26(12):2525-9. PubMed ID: 16023260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
    Rezin GT; Petronilho FC; Araújo JH; Gonçalves CL; Daufenbach JF; Cardoso MR; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):214-9. PubMed ID: 21138529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice.
    Meller CA; Henriques JA; Schwartsmann G; Roesler R
    Peptides; 2004 Apr; 25(4):585-8. PubMed ID: 15165713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinal Functions of B-Type Natriuretic Peptide, Gastrin-Releasing Peptide, and Their Cognate Receptors for Regulating Itch in Mice.
    Kiguchi N; Sukhtankar DD; Ding H; Tanaka K; Kishioka S; Peters CM; Ko MC
    J Pharmacol Exp Ther; 2016 Mar; 356(3):596-603. PubMed ID: 26669425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term behavioral effects of neonatal blockade of gastrin-releasing peptide receptors in rats: similarities to autism spectrum disorders.
    Merali Z; Presti-Torres J; Mackay JC; Johnstone J; Du L; St-Jean A; Levesque D; Kent P; Schwartsmann G; Roesler R; Schroder N; Anisman H
    Behav Brain Res; 2014 Apr; 263():60-9. PubMed ID: 24462726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexamethasone reverses the memory impairment induced by antagonism of hippocampal gastrin-releasing peptide receptors.
    Venturella R; Lessa D; Luft T; Roozendaal B; Schwartsmann G; Roesler R
    Peptides; 2005 May; 26(5):821-5. PubMed ID: 15808912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.
    Schroeder RP; van Weerden WM; Bangma C; Krenning EP; de Jong M
    Methods; 2009 Jun; 48(2):200-4. PubMed ID: 19398012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms mediating gastrin-releasing peptide receptor modulation of memory consolidation in the hippocampus.
    Roesler R; Luft T; Oliveira SH; Farias CB; Almeida VR; Quevedo J; Dal Pizzol F; Schröder N; Izquierdo I; Schwartsmann G
    Neuropharmacology; 2006 Aug; 51(2):350-7. PubMed ID: 16735043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
    Petronilho F; Araújo JH; Steckert AV; Rezin GT; Ferreira GK; Roesler R; Schwartsmann G; Dal-Pizzol F; Streck EL
    Peptides; 2009 Aug; 30(8):1460-5. PubMed ID: 19505518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrin-releasing peptide as a molecular target for inflammatory diseases: an update.
    Petronilho F; Danielski LG; Roesler R; Schwartsmann G; Dal-Pizzol F
    Inflamm Allergy Drug Targets; 2013 Jun; 12(3):172-7. PubMed ID: 23621446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased frequency of gastrin-releasing peptide receptor gene mutations during colon-adenocarcinoma progression.
    Glover SC; Tretiakova MS; Carroll RE; Benya RV
    Mol Carcinog; 2003 May; 37(1):5-15. PubMed ID: 12720295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced NGF secretion by HT-29 human colon cancer cells treated with a GRPR antagonist.
    de Farias CB; Stertz L; Lima RC; Kapczinski F; Schwartsmann G; Roesler R
    Protein Pept Lett; 2009; 16(6):650-2. PubMed ID: 19519524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairments of social behavior and memory after neonatal gastrin-releasing peptide receptor blockade in rats: Implications for an animal model of neurodevelopmental disorders.
    Presti-Torres J; de Lima MN; Scalco FS; Caldana F; Garcia VA; Guimarães MR; Schwartsmann G; Roesler R; Schröder N
    Neuropharmacology; 2007 Mar; 52(3):724-32. PubMed ID: 17097693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.